Human pharmacology of 3,4-methylenedioxymethamphetamine (MDMA, ecstasy) after repeated doses taken 2 h apart

被引：0
|
作者：
A. M. Peiró
M. Farré
P. N. Roset
M. Carbó
M. Pujadas
M. Torrens
J. Camí
R. de la Torre
机构：
[1] IMIM-Hospital del Mar Medical Research Institute,Human Pharmacology and Clinical Neurosciences Research Group, Neurosciences Research Programme
[2] Universitat Autònoma de Barcelona (UDIMAS-UAB),CIBER de Fisiopatología de la Obesidad y Nutrición (CB06/03)
[3] Universitat Pompeu Fabra (CEXS-UPF),undefined
[4] Addiction Unit - INAD,undefined
[5] Doctor Aiguader 88,undefined
[6] CIBEROBN,undefined
来源：
Psychopharmacology | 2013年 / 225卷
关键词：
MDMA; Ecstasy; Repeated dose; Humans; Metabolic inhibition; Pharmacologic effects; Pharmacokinetics; CYP2D6;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：883 / 893
页数：10
相关论文
共 50 条
  • [1] Human pharmacology of 3,4-methylenedioxymethamphetamine (MDMA, ecstasy) after repeated doses taken 2 h apart
    Peiro, A. M.
    Farre, M.
    Roset, P. N.
    Carbo, M.
    Pujadas, M.
    Torrens, M.
    Cami, J.
    de la Torre, R.
    PSYCHOPHARMACOLOGY, 2013, 225 (04) : 883 - 893
  • [2] Human pharmacology of 3, 4-methylenedioxymethamphetamine (MDMA, ecstasy) after repeated doses taken 4 h apart Human pharmacology of MDMA after repeated doses taken 4 h apart
    Farre, Magi
    Tomillero, Angels
    Perez-Mana, Clara
    Yubero, Samanta
    Papaseit, Esther
    Roset, Pere-Nolasc
    Pujadas, Mitona
    Torrens, Marta
    Cami, Jordi
    de la Torre, Rafael
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2015, 25 (10) : 1637 - 1649
  • [3] REVIEW OF THE PHARMACOLOGY AND CLINICAL-PHARMACOLOGY OF 3,4-METHYLENEDIOXYMETHAMPHETAMINE (MDMA OR ECSTASY)
    GREEN, AR
    CROSS, AJ
    GOODWIN, GM
    PSYCHOPHARMACOLOGY, 1995, 119 (03) : 247 - 260
  • [4] 3,4-methylenedioxymethamphetamine (MDMA, ecstasy) and driving impairment
    Logan, BK
    Couper, FJ
    JOURNAL OF FORENSIC SCIENCES, 2001, 46 (06) : 1426 - 1433
  • [5] False-Positive Amphetamine/Ecstasy (MDMA/3,4-Methylenedioxymethamphetamine) (CEDIA) and Ecstasy (MDMA/3,4-Methylenedioxymethamphetamine) (DRI) Test Results With Fenofibrate
    Kaplan, Yusuf Cem
    Erol, Almila
    Karadas, Baris
    THERAPEUTIC DRUG MONITORING, 2012, 34 (05) : 493 - 495
  • [6] Are there sex differences associated with the effects of ecstasy/3,4-methylenedioxymethamphetamine (MDMA)?
    Allott, Kelly
    Redman, Jennifer
    NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS, 2007, 31 (03) : 327 - 347
  • [7] The ecstasy and the agony; compression studies of 3,4-methylenedioxymethamphetamine (MDMA)
    Connor, Lauren E.
    Delori, Amit
    Hutchison, Ian B.
    Daeid, Niamh Nic
    Sutcliffe, Oliver B.
    Oswald, Iain D. H.
    ACTA CRYSTALLOGRAPHICA SECTION B-STRUCTURAL SCIENCE CRYSTAL ENGINEERING AND MATERIALS, 2015, 71 : 3 - 9
  • [8] Chronic tolerance to recreational MDMA (3,4-methylenedioxymethamphetamine) or Ecstasy
    Parrott, AC
    JOURNAL OF PSYCHOPHARMACOLOGY, 2005, 19 (01) : 71 - 83
  • [9] Detection of 3,4-methylenedioxymethamphetamine (MDMA, ecstasy) by displacement of antibodies
    Vikholm-Lundin, Inger
    Auer, Sanna
    Hellgren, Ann-Charlotte
    SENSORS AND ACTUATORS B-CHEMICAL, 2011, 156 (01) : 28 - 34
  • [10] PERSISTENT EFFECTS OF (+/-)3,4-METHYLENEDIOXYMETHAMPHETAMINE (MDMA, ECSTASY) ON HUMAN SLEEP
    ALLEN, RP
    MCCANN, UD
    RICAURTE, GA
    SLEEP, 1993, 16 (06): : 560 - 564
12345